jueves, 23 de marzo de 2017

KISQALI: New Drug Trials Snapshot Posted

FDA Logo
A new  DRUG TRIALS SNAPSHOT is now available.
KISQALI is a drug for treatment of a specific form of advanced breast cancer called hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer in women who have gone through menopause.
See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.

No hay comentarios:

Publicar un comentario